Correlation of serum prostate specific antigen and quantitative immunohistochemistry

Journal of Urology

Volumn 163, Issue 6, 2000, Pages 1739-1742

  Weir, Edward G ^a   Partin, Alan W ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Prostate; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; TUMOR VOLUME;

EID: 0034096909     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67532-5     Document Type: Article

References (27)

1. Lilja, H., Oldbring, J., Rannevik, G. et al: Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest, 80: 281, 1987
2. Chu, T. M. and Murphy, G. P.: What's new in tumor markers for prostate cancer? Urology, 27: 487, 1986
3. Kuriyama, M., Wang, M. C., Lee, C. L. et al: Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res, 41: 3874, 1981
4. Stamey, T. A., Yang, N., Hay, A. R. et al: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med, 317: 909, 1987
5. Partin, A. W., Carter, H. B., Chan, D. W. et al: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. Urology, 143: 747, 1990
6. Stamey, T. A., Kabalin, J. N., McNeal, J. E. et al: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol, 141: 1076, 1989
7. Csapo, Z., Brand, K., Walther, R. et al: Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. J Urol, 140: 1032, 1988
8. Weber, J. P., Oesterling, J. E., Peters, C. A. et al: The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol, 141: 987, 1989
9. Cadeddu, J. A., Pearson, J. D., Lee, B. R. et al: Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia. Urology, 45: 795, 1995
10. Oesterling, J. E., Jacobsen, S. J., Chute, C. G. et al: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA, 270: 860, 1993
11. Collins, G. N., Lee, R. J., McKelvie, G. B. et al: Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol, 71: 445, 1993
12. Svanholm, H.: Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase. Acta Pathol Microbiol Immunol Scand [A], 94: 7, 1986
13. Ellis, D. W., Leffers, S., Davies, J. S. et al: Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol, 81: 279, 1984
14. Stein, B. S., Vangore, S., Petersen, R. O. et al: Immunoperoxidase localization of prostate-specific antigen. Am J Surg Pathol, 6: 553, 1982
15. Abrahamsson, P. A., Lilja, H., Falkmer, S. et al: Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate, 12: 39, 1988
16. Cartun, R. W. and Pedersen, C. A.: An immunocytochemical technique offering increased sensitivity and a lowered cost with a streptavidin horseradish-peroxidase conjugate. J Histotechnol, 12: 273, 1989
17. Carter, H. B., Pearson, J. D., Metter, E. J. et al: Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA, 267: 2215, 1992
18. Partin, A. W., Epstein, J. I., Cho, K. R. et al: Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol, 141: 341, 1989
19. Stenman, U. H., Leinonen, J. and Zhang, W. M.: Problems in the determination of prostate specific antigen. Eur J Clin Chem Clin Biochem, 34: 735, 1996
20. Oesterling, J. E., Chan, D. W., Epstein, J. I. et al: Prostate-specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol, 139: 766, 1988
21. Zhou, A. M., Tewari, P. C., Bluestein, B. I. et al: Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem, 39: 2483, 1993
22. Espana, F., Sanchez-Cuenca, J., Estelles, A. et al: Quantitative immunoassay for complexes of prostate-specific antigen with alpha-2-macroglobulin. Clin Chem, 42: 545, 1996
23. Stenman, U. H., Hakama, M., Knekt, P. et al: Serum concentrations of prostate specific antigen and its complex with alpha-1-antichymotrypsin before diagnosis of prostate cancer. Lancet, 344: 1594, 1994
24. Christensson, A., Laurell, C. B. and Lilja, H.: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine protease inhibitors. Eur J Biochem, 194: 755, 1990
25. Stenman, U. H., Leinonen, J., Alfthan, H. et al: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res, 51: 222, 1991
26. McCormack, R. T., Rittenhouse, H. G., Finlay, J. A. et al: Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology, 45: 729, 1995
27. Pettersson, K., Piironen, T., Seppala, M. et al: Free and complexed prostate specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha-1-antichymotrypsin complex. Clin Chem, 41: 1480, 1995